Canadian Association of Radiologists Journal
Volume 62, Issue 3 , Pages 166-175.e5 , August 2011

Canadian Association of Radiologists Technical Standards for Bone Mineral Densitometry Reporting

  • Kerry Siminoski, MD, FRCPC

      Affiliations

    • Department of Radiology and Diagnostic Imaging and Division of Endocrinology and Metabolism, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationAddress for correspondence: Kerry Siminoski, MD, FRCPC, Department of Radiology and Diagnostic Imaging, University of Alberta, 6628-123 Street, Edmonton, Alberta T6H 3T6, Canada.
    • ,
  • Margaret O'Keeffe, MD, FRCPC

      Affiliations

    • Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Jacques Lévesque, MD, FRCPC

      Affiliations

    • Department of Radiology, Le Centre hospitalier universitaire de Québec, Québec, Québec, Canada
    • ,
  • David Hanley, MD, FRCPC

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; representing the Canadian Panel of the International Society for Clinical Densitometry
    • ,
  • Jacques P. Brown, MD, FRCPC

      Affiliations

    • Division of Rheumatology, Department of Medicine, Laval University, Le Centre hospitalier universitaire de Québec, Québec, Québec, Canada; representing the Scientific Advisory Council of Osteoporosis Canada

References 

  1. Siminoski K, Leslie WD, Frame H, et al. Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J. 2005;56:178–188
  2. Brown JP, Josse RG for the Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J. 2002;167:S1–34
  3. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. WHO Technical Report Series. Geneva: WHO; 1994;
  4. Simonelli C, Adler RA, Blake GM, et al. Dual-energy x-ray absorptiometry technical issues: the 2007 ISCD official positions. J Clin Densitom. 2008;11:109–122
  5. Khan AA, Brown J, Faulkner K, et al. Standards and guidelines for performing central dual x-ray densitometry from the Canadian panel of International Society for Clinical Densitometry. J Clin Densitom. 2002;5:435–444
  6. Hamdy RC, Kiebzak GM. Variance in 10-year fracture risk calculated with and without T-scores in select subgroups of normal and osteoporotic patients. J Clin Densitom. 2009;12:158–161
  7. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–1259
  8. Cranney A, Tugwell P, Wells G, et al. Systematic reviews of randomized trials in osteoporosis: introduction and methodology. Endocrin Rev. 2002;23:497–507
  9. Kanis JA, Borgstrom F, De Laet C, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581–589
  10. Bhambri R, Naik V, Malhotra N, et al. Changes in bone mineral density following treatment of osteomalacia. J Clin Densitom. 2006;9:120–127
  11. Sebba AI. Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment. Clin Ther. 2008;30:443–452
  12. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: scientific review. JAMA. 2002;288:1889–1897
  13. Cummings SR, Cawthon PM, Ensrud KE, et al. BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women. J Bone Miner Res. 2006;21:1550–1556
  14. Siminoski K, Leslie WD, Frame H, et al. Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment. J Clin Densitom. 2007;10:120–123
  15. Blake GM, Fogelman I. Role of dual-energy x-ray absorptiometry in the diagnosis and treatment of osteoporosis. J Clin Densitom. 2007;10:102–110
  16. Robbins J, Aragaki AK, Kooperberg C, et al. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA. 2007;298:2389–2398
  17. Kosowicz J, El Ali Z, Ziemnicka K, et al. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism. J Clin Densitom. 2007;10:332–339
  18. Baim S, Binkley N, Bilezikian JP, et al. Official positions of the International Society for Clinical Densitometry and executive summary of 2007 ISCD position development conference. J Clin Densitom. 2008;11:75–91
  19. American College of Radiology. Practice guideline for the performance of dual-energy x-ray absorptiometry (DXA). 2008. Available at: www.acr.org. Accessed May 12, 2010.
  20. Baim S, Leonard MB, Bianchi M, et al. Official positions of the International Society for Clinical Densitometry and executive summary of 2007 ISCD pediatric position development conference. J Clin Densitom. 2008;11:6–21
  21. Bishop N, Baillon P, Burnham J, et al. Dual-energy x-ray absorptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD pediatric official positions. J Clin Densitom. 2008;11:29–42
  22. Leslie WD, Tsang JF, Lix L Manitoba Bone Density Program. Simplified system for absolute fracture risk assessment: clinical validation in Canadian women. J Bone Miner Res. 2009;24:353–360
  23. Richards J, Leslie W, Joseph L, et al. Changes to osteoporosis prevalence according to method of risk assessment. J Bone Miner Res. 2007;22:228–234
  24. Bonnick SL. Bone densitometry in clinical practice. 3rd ed.. Totowa (NJ): Humana Press; 2009;
  25. Bonnick SL, Lewis LA. Bone densitometry for technologists. 2nd ed.. Totowa, (NJ: Humana Press; 2006;
  26. In:  Sawyer A,  Bachrach LK,  Fung EB editor. Bone densitometry in growing patients. Totowa (NJ): Humana Press; 2007;
  27. Binkley N, Krueger D. What should DXA reports contain? Preferences of ordering health care providers. J Clin Densitom. 2009;12:5–10
  28. Johansson H, Kanis JA, Oden A, et al. BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int. 2009;20:1675–1682
  29. Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35:375–382
  30. Adachi JD, Olszynski WP, Hanley DSA, et al. Management of corticosteroid-induced osteoporosis. Semin Arthritis Rheum. 2000;29:228–251
  31. Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004;19:893–899
  32. Papaioannou A, Kennedy C, Cranney A, et al. Risk factors for low bone mass in healthy men age 50 years or older: a systematic review. Osteoporos Int. 2009;20:507–518
  33. Waugh EJ, Lam M, Hawker GA, et al. Risk factors for low bone mass in healthy 40-60 year old women: a systematic review of the literature. Osteoporos Int. 2008;20:1–21
  34. Durosier C, Hans D, Krieg M, et al. Prediction and discrimination of osteoporotic hip fracture risk in postmenopausal women. J Clin Densitom. 2006;9:475–495
  35. Lewiecki EM, Watts NB. Assessing response to osteoporosis therapy. Osteoporos Int. 2008;19:1363–1368
  36. Bonnick SL, Shulman L. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?. Am J Med. 2006;19:S25–S31
  37. West SL, Savitz DA, Koch G, et al. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol. 1995;142:1103–1112
  38. Stock JL, Waud CE, Coderre JA, et al. Clinical reporting to primary care physicians leads to increased use and understanding of bone densitometry and affects the management of osteoporosis. A randomized trial. Ann Intern Med. 1998;128:996–999
  39. Ridout R, Hawker GA. Use of bone densitometry by Ontario family physicians. Osteoporos Int. 2000;11:393–399
  40. Lewiecki EM, Binkley N, Petak SM. DXA quality matters. J Clin Densitom 9:388–392.
  41. National Health and Nutrition Examination Survey III. Body measurement (anthropometry). 1988. Available at: www.cdc.gov. Accessed May 12, 2010.
  42. Lipman TH, McGinley A, Hughes J, et al. Evaluation of the accuracy of height assessment of premenopausal and menopausal women. J Obstet Gynecol Neonat Nurs. 2006;35:516–522
  43. Siminoski K, Jiang G, Adachi JD, et al. Accuracy of height loss during prospective monitoring for the detection of incident vertebral fractures. Osteoporos Int. 2005;16:403–410
  44. Siminoski K, Warshawski RS, Jen H, et al. The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal women. Osteoporos Int. 2006;17:290–296
  45. Vokes TJ, Gillen DL, Lovett J, et al. Comparison of T-scores from different skeletal sites in differentiating postmenopausal women with and without prevalent vertebral fractures. J Clin Densitom. 2005;8:206–215
  46. Pearson D, Horton B, Green DJ. Cross calibration of Hologic QDR2000 and GE Lunar Prodigy for forearm bone mineral density measurements. J Clin Densitom. 2007;10:306–311
  47. Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and non-vertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006;81:1013–1022
  48. Sheehy O, Kindundu C, Barbeau M, et al. Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures. Osteoporos Int. 2009;20:1583–1594
  49. Penning-van Beest FJA, Erkens JA, Olson M, et al. Loss of treatment benefit due to low compliance with bisphosphonate therapy. Osteoporos Int. 2007;19:511–517
  50. Blouin J, Dragomir A, Moride Y, et al. Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. Br J Clin Pharmacol. 2008;66:117–127
  51. Briesacher BA, Andrade SE, Yood RA, et al. Consequences of poor compliance with bisphosphonates. Bone. 2007;41:882–887
  52. Caro JJ, Ishak KJ, Huybrechts KF, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int. 2004;15:1003–1008
  53. Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int. 2001;12:989–995
  54. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;9:385–397
  55. Melton LJ, Atkinson EJ, Khosla S, et al. Evaluation of a prediction model for long-term fracture risk. J Bone Miner Res. 2005;20:551–556
  56. Eddy D, Johnston CC, Cummings SR, et al. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoporos Int. 1998;8:1–88
  57. Van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology. 2000;39:1383–1389
  58. McKiernan F, Washington W. Effect of subtle positioning flaws on measured bone mineral density of the hip. J Clin Densitom. 2005;8:330–334
  59. Leslie WD for the Manitoba Bone Density Program. The impact of bone area on short-term bone density precision. J Clin Densitom. 2006;9:150–153
  60. Kline GA, Hanley DA. Differences of vertebral area in serial bone density measurements: a common source of potential error in interpretation of BMD change. J Clin Densitom. 2006;9:419–424
  61. Baim S, Wilson CR, Lewiecki EM, et al. Precision assessment and radiation safety for dual-energy x-ray absorptiometry. J Clin Densitom. 2005;8:371–378
  62. Lekamwasam S, Rodrigo M, Kodikara Arachchi W, et al. Measurement of spinal bone mineral density on a Hologic Discovery DXA scanner with and without leg elevation. J Clin Densitom. 2007;10:170–173
  63. Khan AA, Colquhoun A, Hanley DA, et al. Standards and guidelines for technologists performing central dual-energy x-ray absorptiometry. J Clin Densitom. 2007;10:189–195
  64. Khan AA, Brown JP, Kendler DL, et al. The 2002 Canadian bone densitometry recommendations: take-home messages. CMAJ. 2002;167:1141–1145
  65. Watts NB. Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA). Osteoporos Int. 2004;15:847–854
  66. Bachrach LK. Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition: promise and pitfalls. J Pediatr Endocrinol Metab. 2000;13(Suppl 2):983–988
  67. Laskey MA, Flaxman ME, Barber RW, et al. Comparative performance in vitro and in vivo of Lunar DPX and Hologic QDR-1000 dual energy x-ray absorptiometers. Br J Radiol. 1991;64:1023–1029
  68. Fink HA, Harrison SL, Taylor BC, et al. Differences in site-specific fracture risk among older women with discordant results for osteoporosis at hip and spine. J Clin Densitom. 2008;11:250–259
  69. Hamdy RC, Petak SM, Lenchik L. Which central dual x-ray absorptiometry site should be used to determine the diagnosis of osteoporosis?. J Clin Densitom. 2002;5:S11–S18
  70. Tsang JF, Leslie WD. Exclusion of focal vertebral artifacts from spine bone densitometry and fracture prediction: a comparison of expert physicians, three computer algorithms, and the minimum vertebra. J Bone Miner Res. 2007;22:789–798
  71. Chen P, Miller PD, Binkley NC, et al. Use of lowest single lumbar spine vertebra bone mineral density T-score and other T-score approaches for diagnosing osteoporosis and relationships to vertebral fracture status. J Clin Densitom. 2008;11:525–531
  72. Hansen KE, Binkley N, Christian R, et al. Interobserver reproducibility of criteria for vertebral body exclusion. J Bone Miner Res. 2005;20:501–508
  73. Cole R, Larson J. The effect of measurement of the contralateral hip if the spine is not included in the bone mineral density analysis. J Clin Densitom. 2006;9:210–216
  74. Yang RS, Tsai KS, Chieng PU, et al. Symmetry of bone mineral density at the proximal femur with emphasis on the effect of side dominance. Calcif Tissue Int. 1997;61:189–191
  75. Carey JJ, Delaney MF, Love TE, et al. DXA-generated Z-scores and T-scores may differ substantially and significantly in young adults. J Clin Densitom. 2007;10:351–358
  76. Binkley N, Krueger D, Vallarta-Ast N. An overlying fat panniculus affects femur bone mass measurement. J Clin Densitom. 2003;6:199–204
  77. Ott SM, Ichikawa LE, LaCroix AZ, et al. Navel jewelry artifacts and intravertebral variation in spine bone densitometry in adolescents and young women. J Clin Densitom. 2009;12:84–88
  78. Yu W, Gluer CC, Fuerst T, et al. Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women. Calcif Tissue Int. 1995;57:169–174
  79. Krege JH, Miller PD, Lenchik L, et al. New or worsening lumbar spine vertebral fractures increase lumbar spine bone mineral density and falsely suggest improved skeletal status. J Clin Densitom. 2006;9:144–149
  80. Reid IR, Evans MC, Ames R, et al. The influence of osteophytes and aortic calcification on spinal mineral density in post-menopausal women. J Clin Endocrinol Metab. 1991;72:1372–1377
  81. Kendler DL, Kiebzak GM, Ambrose CG, et al. Effect of calcium tablets on interpretation of lumbar spine DXA scans. J Clin Densitom. 2006;9:97–104
  82. Jaovisdha S, Sartoris DJ, Martin EM, et al. Influence of spondylopathy on bone densitometry using dual energy x-ray absorptiometry. Calcif Tissue Int. 1997;60:424–429
  83. Jacobsen JA, Jamadar DA, Hayes CW. Dual X-ray absorptiometry: recognizing image artifacts and pathology. AJR Am J Roentgenol. 2000;174:1699–1705
  84. Morgan SL, Lopez-Ben R, Nunnally N, et al. “Black hole artifacts”: a new potential pitfall for DXA accuracy?. J Clin Densitom. 2008;11:266–275
  85. Labio ED, Del Rosario DB, Strasser SI, et al. Effect of ascites on bone mineral measurements in cirrhosis. J Clin Densitom. 2007;10:391–394
  86. Hauache OM, Vieira JGH, Alonso G, et al. Increased hip bone mineral density in a woman with gluteal silicon implant. J Clin Densitom. 2000;3:391–393
  87. Krueger D, Checovich M, Gemar D, et al. Calcium supplement ingestion may alter lumbar spine bone mineral density measurement. J Clin Densitom. 2006;9:159–163
  88. Evans EM, Mojtahedi MC, Kessinger RB, et al. Simulated change in body fatness affects Hologic QDR 4500A whole body and central DXA bone measures. J Clin Densitom. 2006;9:315–322
  89. McKiernan FE, Hocking J, Cournoyer S. Antecedent 99mTc-MDP and 99mTc-sestamibi administration corrupts bone mineral density measured by DXA. J Clin Densitom. 2006;9:164–166
  90. Sala A, Webber C, Halton J, et al. Effect of diagnostic radioisotopes and radiographic contrast media on measurements of lumbar spine bone mineral density and body composition by dual-energy x-ray absorptiometry. J Clin Densitom. 2006;9:91–96
  91. Bertelloni S, Baroncelli GI, Ferdeghini M, et al. Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty. J Clin Endocrinol Metab. 1998;83:4280–4283
  92. Karlsson MK, Weigall SJ, Duan Y, et al. Bone size and volumetric density is women with anorexia nervosa receiving estrogen replacement therapy and in women recovered from anorexia nervosa. J Clin Endocrinol Metab. 2000;85:3177–3182
  93. Gravholt CH, Lauridsen AL, Brixen K, et al. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome: a cross-sectional study. J Clin Endocrinol Metab. 2002;87:2798–2808
  94. Pors Nielsen S, Kolthoff N, Barenholdt O, et al. Diagnosis of osteoporosis by planar bone densitometry: can body size be disregarded?. Br J Radiol. 1998;71:934–943
  95. Blake GM, Herd RJM, Patel R, et al. The effect of weight change on total body dual-energy x-ray absorptiometry: results from a clinical trial. Osteoporos Int. 2000;11:832–839
  96. Tothill P. Dual-energy x-ray absorptiometry measurements of total body bone mineral during weight change. J Clin Densitom. 2005;8:31–38
  97. Hochberg MC, Greenspan S, Wasnich RD, et al. Changes in bone density and turnover explain the reductions in incidence on nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab. 2002;12:281–289
  98. Cranney A, Guyatt G, Griffith L, et al. Meta-analyses of therapies for postmenopausal osteoporosis. IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocrin Rev. 2002;23:570–578
  99. Bonnick SL. Monitoring osteoporosis therapy with bone densitometry: a vital tool or regression towards mediocrity?. J Clin Endocrinol Metab. 2000;85:3493–3495
  100. Wasnich RD, Miller PD. Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab. 2000;85:231–236
  101. Cummings SR, Palermo L, Browner W, et al. Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. JAMA. 2000;283:1318–1321
  102. Lenchik L, Kiebzak GM, Blunt BA. What is the role of serial bone density measurements in patient management?. J Clin Densitom. 2002;5:S29–S38
  103. Phillipov G, Seaborn CJ, Phillips PJ. Reproducibility of DEXA: potential impact on serial measurements and misclassification of osteoporosis. Osteoporos Int. 2001;12:49–54
  104. Pouilles J, Tremollieres F, Todorovsky N, et al. Precision and sensitivity of dual-energy x-ray absorptiometry in spinal osteoporosis. J Bone Miner Res. 1991;6:997–1002
  105. Gluer CC, Blake G, Lu Y, et al. Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques. Osteoporos Int. 1995;5:262–270
  106. Bonnick SL, Johnston CC, Kleerekoper M, et al. Importance of precision in bone density measurements. J Clin Densitom. 2001;4:105–110
  107. Leslie WD, Moayyeri A. Minimum sample size requirements for bone density precision assessment produce inconsistency in clinical monitoring. Osteoporos Int. 2006;17:1673–1680
  108. Leslie WD. Factors affecting short-term bone density precision assessment and the effect on patient monitoring. J Bone Miner Res. 2008;23:199–204
  109. Shepherd JA, Lu Y. A generalized least significant change for individuals measured on different DXA systems. J Clin Densitom. 2007;10:249–258
  110. Bennett HS, Dienstfrey A, Hudson LT, et al. Standards and measurements for assessing bone health-workshop report co-sponsored by the International Society for Clinical Densitometry (ISCD) and the National Institute of Standards and Technology (NIST). J Clin Densitom. 2006;9:399–405
  111. Shepherd JA, Lu Y, Wilson K, et al. Cross-calibration and minimum precision standards for dual-energy x-ray absorptiometry: the 2005 ISCD official positions. J Clin Densitom. 2006;9:31–36
  112. Gordon CM, Bachrach LK, Carpenter TO, et al. Dual energy x-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD pediatric official positions. J Clin Densitom. 2008;11:43–58
  113. Rauch F, Plotkin H, DiMeglio L, et al. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 pediatric official position. J Clin Densitom. 2008;11:22–28
  114. Binkovitz LA, Henwood MJ, Sparke P. Pediatric DXA: technique, interpretation, and clinical applications. Pediatr Radiol. 2008;8:S227–S239
  115. Ellis KJ, Shypailo RJ, Hardin DS, et al. Z-score prediction model for assessment of bone mineral content in pediatric diseases. J Bone Miner Res. 2001;16:1658–1664
  116. Gafni RI, Baron J. Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy X-ray absorptiometry (DEXA). J Pediatr. 2004;144:253–257
  117. Cromer BA, Binkovitz L, Ziegler J, et al. Reference values for bone mineral density in 12- to 18-year old girls categorized by weight, race, and age. Pediatr Radiol. 2004;34:787–792
  118. Goulding A, Jones IE, Taylor RW, et al. Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. J Pediatr. 2001;139:509–515
  119. Bachrach LK. Osteoporosis and measurement of bone mass in children and adolescents. Endocrinol Metab Clin North Am. 2005;34:521–535
  120. Gordon CM. Measurement of bone density in children. Curr Opin Endocrinol Metab. 2005;12:444–451
  121. Soyka LA, Fairfield WP, Klibanski A. Hormonal determinants and disorders of peak bone mass in children. J Clin Endocrinol Metab. 2000;85:3951–3963
  122. Halton J, Gaboury I, Grant R, et al. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-associated Osteoporosis in the Pediatric Population (STOPP) Research Program. J Bone Miner Res. 2009;24:1326–1334
  123. Burnham JM, Shults J, Semeao E, et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res. 2004;19:1961–1968
  124. Bielinski BK, Darbyshire PJ, Mathers L, et al. Impact of disordered puberty on bone density in beta-thalassaemia major. Br J Haematol. 2003;120:353–358
  125. Miller KK, Lee EE, Lawson EA, et al. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab. 2006;91:2931–2937
  126. Jones G, Ma D, Cameron F. Bone density interpretation and relevance in Caucasian children aged 9-17 years of age: insights from a population-based fracture study. J Clin Densitom. 2006;9:202–209
  127. Warner JT, Cowan FJ, Dunstan FD, et al. Measured and predicted bone mineral content in healthy boys and girls aged 6-18 years: adjustment for body size and puberty. Acta Paediatr. 1998;87:244–249
  128. Barnes C, Newall F, Ignatovic V, et al. Reduced bone density in children on long-term warfarin. Pediatr Res. 2005;57:578–581
  129. Binkley N, Bilezikian JP, Kendler DL, et al. Official positions of the International Society for Clinical Densitometry and executive summary of the 2005 position development conference. J Clin Densitom. 2006;9:4–14
  130. Mul D, van Suijlekom-Smit LW, ten Cate R, et al. Bone mineral density and body composition and influencing factors in children with rheumatic disease treated with corticosteroids. J Pediatr Endocrinol Metab. 2002;15:187–192
  131. Webber CE, Sala A, Barr RD. Accounting for body size deviations when reporting bone mineral density variables in children. Osteoporos Int. 2009;20:113–121
  132. Cole JH, Dowthwaite JN, Scerpella TA, et al. Correcting fan-beam magnification in clinical densitometry scans of growing subjects. J Clin Densitom. 2009;12:322–329
  133. Smith CM, Coombs RC, Gibson AT, et al. Adaptation of the Carter method to adjust lumbar spine bone mineral content for age and body size: application to children who were born preterm. J Clin Densitom. 2006;9:114–119
  134. Crabtree NJ, Kibirige MS, Fordham JN, et al. The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone. 2004;35:965–972
  135. Hammami M, Koo WW, Hockman EM. Technical considerations for fan-beam dual-energy X-ray absorptiometry body composition measurements in pediatric studies. J Parenter Enteral Nutr. 2004;28:328–332
  136. The Writing Group for the ISCD (2004) Position Development Conference: diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom. 2004;7:17–26
  137. Cheng S, Nicholson PHF, Kroger H, et al. Difference in estimates of change of bone accrual and body composition in children because of scan mode selection with the Prodigy densitometer. J Clin Densitom. 2005;8:65–73
  138. Simpson DE, Dontu VS, Stephens SE, et al. Large variations occur in bone density measurements of children when using different software. Nucl Med Commun. 2005;26:483–487
  139. Faulkner RA, Bailey DA, Drinkwater DT, et al. Regional and total body bone mineral content, bone mineral density, and total body tissue composition in children 8-16 years of age. Calcif Tissue Int. 1993;53:7–12
  140. Margulies L, Horlick M, Thornton JC, et al. Reproducibility of pediatric whole body bone and body composition measures by dual-energy X-ray absorptiometry using the GE Lunar prodigy. J Clin Densitom. 2005;8:298–304
  141. Glastre C, Braillon P, David L, et al. Measurement of bone mineral content of the lumbar spine by dual energy X-ray absorptiometry in normal children: correlations with growth parameters. J Clin Endocrinol Metab. 1990;70:1330–1333

 All appendices cited in this article are available via the CARJ website at www.carjonline.org.

PII: S0846-5371(10)00109-9

doi: 10.1016/j.carj.2010.04.007

Canadian Association of Radiologists Journal
Volume 62, Issue 3 , Pages 166-175.e5 , August 2011

Article Tools